Broadcast Date: October 12, 2020
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Biopharmaceutical firms are transitioning from the event of ordinary monoclonal antibody therapies to extra intricate antibody constructions and new genetic medicines. Not solely are these molecules extra complicated, however scientists are additionally underneath large strain to know molecular liabilities sooner and shut the developability hole in a a lot shorter timeframe. As such, analytical analysis of those subtle samples is getting extra complicated, extra quite a few, and outcomes are required in much less time. Because of this, investigators are in dire want of applied sciences which are quick and strong sufficient to maintain up with the event tempo of next-generation biotherapeutics.
On this GEN webinar, we’ll take a more in-depth take a look at the newest applied sciences purpose-built to satisfy the challenges of the biopharmaceutical trade. As an example, we’ll hear particulars a couple of multi-capillary electrophoresis system that permits researchers to run a number of samples considerably quicker than conventional strategies, permitting for high-throughput evaluation of protein purity and stability, in addition to genome integrity and AAV purity. For complicated protein therapeutic evaluation, we’ll be taught extra a couple of novel LC-MS/MS QTOF instrument, in addition to the software program purposes and superior information processing capabilities employed to offer full pattern characterization, together with impurities identification.
A stay Q&A session will comply with the presentation, providing you an opportunity to pose inquiries to our skilled panelist.